Vima Access pulls formulary status, prescribing trends, clinical system listings, wholesaler audits, and reimbursement into one place. Then it gives your team the tools to track launches, suggest formulary changes, raise tickets, and watch the drugs that matter, daily.
Most market access teams piece together data from three or four sources, plus a spreadsheet or two. None of those tools gives a single place to act. Vima Access starts where they stop, then adds the operational layer none of them have.
Every panel cites its source and shows when it was last verified, by whom. Quarterly review cycle on curated data, weekly refresh on dm+d and prescribing.
Four built-in tools that sit on top of the panels so your team does the work in one place, not five.
Purpose-built for UK pharma launches, end to end. Vima’s Launch Tracker takes a drug from MHRA approval through wholesaler stocking, EMIS and SystmOne listings, and the first six months of prescribing growth, in one view. It detects what it can from the panels and surfaces slip-risk warnings when the dm+d effective date drifts past the cadence expected for each downstream system.
Vimaxa is a fictional combination inhaler shown for illustration. All other figures (ICB names, wholesalers, dates) are consistent with how the platform operates with real product data.
“After years working on NHS primary care market access, the same gap kept showing up. The data layer is necessary, but it is not sufficient. Vima Access is built to be both layers in one.”
Designed to scale with your portfolio, with volume bands that get more efficient as the SKU count grows. Launch Tracker is an optional add-on for SKUs in active launch.
Annual fee per SKU on a four-band volume scale. Cost per SKU gets more efficient as your portfolio grows. Minimum annual fee. Two-year default contract, annual billing up front.
One-time fee per SKU joining the platform. Covers dm+d mapping, baseline formulary research, listing verification, wholesaler audit, reimbursement classification.
Optional, priced per launch event. Charged when a new SKU is onboarded or a pack change is initiated. Includes the full launch lifecycle: MHRA approval through six months post first prescription.
Tell us which products you’d want to see and we’ll prepare a tailored demo with real data, typically within five working days.